本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Achieve Life Sciences, Inc.

2.06
-0.1250-5.73%
成交量:149.57万
成交额:308.21万
市值:1.06亿
市盈率:-1.54
高:2.16
开:2.14
低:2.02
收:2.18
数据加载中...
2021/12/22

重要事件披露

8-K - Current report
2021/08/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/05/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/05/25

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/15

重要事件披露

8-K - Current report
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/30

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses